Skip to main content

Main menu

  • Home
  • Content
    • Published Ahead of Print
    • Current Issue
    • Podcasts
    • Subject Collections
    • Archives
    • ASN Meeting Abstracts
    • Saved Searches
  • Authors
    • Submit a Manuscript
    • Author Resources
    • Reprint Information
  • Trainees
    • Peer Review Program
    • Prize Competition
  • About CJASN
    • About CJASN
    • Editorial Team
    • CJASN Impact
    • CJASN Recognitions
  • More
    • Alerts
    • Advertising
    • Reprint Information
    • Subscriptions
    • Feedback
  • ASN Kidney News
  • Other
    • JASN
    • Kidney360
    • Kidney News Online
    • American Society of Nephrology

User menu

  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
American Society of Nephrology
  • Other
    • JASN
    • Kidney360
    • Kidney News Online
    • American Society of Nephrology
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Advertisement
American Society of Nephrology

Advanced Search

  • Home
  • Content
    • Published Ahead of Print
    • Current Issue
    • Podcasts
    • Subject Collections
    • Archives
    • ASN Meeting Abstracts
    • Saved Searches
  • Authors
    • Submit a Manuscript
    • Author Resources
    • Reprint Information
  • Trainees
    • Peer Review Program
    • Prize Competition
  • About CJASN
    • About CJASN
    • Editorial Team
    • CJASN Impact
    • CJASN Recognitions
  • More
    • Alerts
    • Advertising
    • Reprint Information
    • Subscriptions
    • Feedback
  • ASN Kidney News
  • Visit ASN on Facebook
  • Follow CJASN on Twitter
  • CJASN RSS
  • Community Forum
Original ArticlesClinical Nephrology
You have accessRestricted Access

Rituximab as Maintenance Therapy for Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis

Eugene P. Rhee, Karen A. Laliberte and John L. Niles
CJASN August 2010, 5 (8) 1394-1400; DOI: https://doi.org/10.2215/CJN.08821209
Eugene P. Rhee
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Karen A. Laliberte
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
John L. Niles
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data Supps
  • Info & Metrics
  • View PDF
Loading

Abstract

Background and objectives: Ongoing randomized trials seek to validate the efficacy of rituximab as an induction agent for anti-neutrophil cytoplasmic antibody (ANCA)-associated vasculitis (AAV). However, no studies directly address the role of rituximab as maintenance therapy.

Design, setting, participants, & measurements: This retrospective study reports the authors' experience with continuous rituximab administration in 39 patients in complete or partial remission at the time of rituximab initiation. All 39 patients had at least 1 year of follow-up, and 20 had 2 years of follow-up.

Results: Disease activity, as measured by a modified Birmingham Vasculitis Activity Score, decreased from a median of 1 at baseline to 0 at 12 (P < 0.001) and 24 months (P = 0.02). Three patients experienced nonorgan-threatening flares during 708 patient-months of follow-up. Each flare occurred after at least 20 months of follow-up. The percentage of patients on cytotoxic immunosuppression decreased from 87% at baseline to 41% at 12 months (P < 0.001) and 30% at 24 months (P = 0.002). The percentage of patients on prednisone decreased from 92% at baseline to 59% at 12 months (P < 0.001) and 55% at 24 months (P = 0.02). Two patients developed late-onset neutropenia; both responded to treatment with recombinant granulocyte colony-stimulating factor.

Conclusions: The successful use of continuous anti-B cell therapy in patients with AAV in complete or partial remission is reported. This extends the potential role of rituximab beyond induction to include maintenance therapy. However, more data are required regarding the delayed adverse effects of rituximab.

Footnotes

    • Received December 8, 2009.
    • Accepted April 13, 2010.
    • Copyright © 2010 by the American Society of Nephrology
    View Full Text
    PreviousNext
    Back to top

    In this issue

    Clinical Journal of the American Society of Nephrology
    Vol. 5, Issue 8
    1 Aug 2010
    • Table of Contents
    • Table of Contents (PDF)
    • Index by author
    View Selected Citations (0)
    Print
    Download PDF
    Sign up for Alerts
    Email Article
    Thank you for your help in sharing the high-quality science in CJASN.
    Enter multiple addresses on separate lines or separate them with commas.
    Rituximab as Maintenance Therapy for Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis
    (Your Name) has sent you a message from American Society of Nephrology
    (Your Name) thought you would like to see the American Society of Nephrology web site.
    CAPTCHA
    This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
    Citation Tools
    Rituximab as Maintenance Therapy for Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis
    Eugene P. Rhee, Karen A. Laliberte, John L. Niles
    CJASN Aug 2010, 5 (8) 1394-1400; DOI: 10.2215/CJN.08821209

    Citation Manager Formats

    • BibTeX
    • Bookends
    • EasyBib
    • EndNote (tagged)
    • EndNote 8 (xml)
    • Medlars
    • Mendeley
    • Papers
    • RefWorks Tagged
    • Ref Manager
    • RIS
    • Zotero
    Request Permissions
    Share
    Rituximab as Maintenance Therapy for Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis
    Eugene P. Rhee, Karen A. Laliberte, John L. Niles
    CJASN Aug 2010, 5 (8) 1394-1400; DOI: 10.2215/CJN.08821209
    del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
    • Tweet Widget
    • Facebook Like

    Jump to section

    • Article
      • Abstract
      • Materials and Methods
      • Results
      • Discussion
      • Disclosures
      • Acknowledgments
      • Footnotes
      • References
    • Figures & Data Supps
    • Info & Metrics
    • View PDF

    More in this TOC Section

    Original Articles

    • Trends in Discard of Kidneys from Hepatitis C Viremic Donors in the United States
    • Availability, Accessibility, and Quality of Conservative Kidney Management Worldwide
    • Zolpidem Versus Trazodone Initiation and the Risk of Fall-Related Fractures among Individuals Receiving Maintenance Hemodialysis
    Show more Original Articles

    Clinical Nephrology

    • Systematic Review and Meta-Analysis of Native Kidney Biopsy Complications
    • Major Bleeding and Risk of Death after Percutaneous Native Kidney Biopsies
    • COVID-19 Outbreak and Management Approach for Families with Children on Long-Term Kidney Replacement Therapy
    Show more Clinical Nephrology

    Cited By...

    • The Search for a Biomarker of Relapse in ANCA-Associated Vasculitis
    • Repeat cycles of rituximab on clinical relapse in ANCA-associated vasculitis: identifying B cell biomarkers for relapse to guide retreatment decisions
    • Long-Term Maintenance Therapy Using Rituximab-Induced Continuous B-Cell Depletion in Patients with ANCA Vasculitis
    • Could we abandon cyclophosphamide in systemic vasculitis and lupus nephritis?
    • Documentation of off-label use of biologics in Rheumatoid Arthritis
    • Decreased CD5+ B Cells in Active ANCA Vasculitis and Relapse after Rituximab
    • Long-Term Remissions of Severe Pemphigus After Rituximab Therapy Are Associated with Prolonged Failure of Desmoglein B Cell Response
    • Updated consensus statement on biological agents for the treatment of rheumatic diseases, 2011
    • Efficacy of rituximab in primary Sjogren's syndrome with peripheral nervous system involvement: results from the AIR registry
    • Rituximab Maintenance Therapy for Granulomatosis with Polyangiitis and Microscopic Polyangiitis
    • B Cell Strategy to Maintain Remission in ANCA-associated Vasculitides?
    • Rituximab Treatment for Vasculitis
    • Google Scholar

    Similar Articles

    Related Articles

    • Rituximab Treatment for Vasculitis
    • PubMed
    • Google Scholar

    Articles

    • Current Issue
    • Early Access
    • Subject Collections
    • Article Archive
    • ASN Meeting Abstracts

    Information for Authors

    • Submit a Manuscript
    • Trainee of the Year
    • Author Resources
    • ASN Journal Policies
    • Reuse/Reprint Policy

    About

    • CJASN
    • ASN
    • ASN Journals
    • ASN Kidney News

    Journal Information

    • About CJASN
    • CJASN Email Alerts
    • CJASN Key Impact Information
    • CJASN Podcasts
    • CJASN RSS Feeds
    • Editorial Board

    More Information

    • Advertise
    • ASN Podcasts
    • ASN Publications
    • Become an ASN Member
    • Feedback
    • Follow on Twitter
    • Password/Email Address Changes
    • Subscribe

    © 2021 American Society of Nephrology

    Print ISSN - 1555-9041 Online ISSN - 1555-905X

    Powered by HighWire